← Career intelligence
Free · no sign-up · 3,138 priced deals

The deal tape

A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.

What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.

What this cut was bought at

Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.

MeasureDeals25thMedian75th
EV / LTM EBITDA357.7x10.3x12.4x
EV / LTM revenue450.6x1.2x2.0x
Premium to unaffected price6520%37%56%
Premium to 30-day VWAP428%36%47%

Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.

Deals by year of announcement
0651292009: 7 deals, 1 clean on every measure200972010: 85 deals, 16 clean on every measure2010852011: 92 deals, 46 clean on every measure2011922012: 111 deals, 64 clean on every measure20121112013: 111 deals, 71 clean on every measure20131112014: 114 deals, 50 clean on every measure20141142015: 117 deals, 57 clean on every measure20151172016: 117 deals, 63 clean on every measure20161172017: 114 deals, 51 clean on every measure20171142018: 123 deals, 62 clean on every measure20181232019: 118 deals, 59 clean on every measure20191182020: 92 deals, 43 clean on every measure2020922021: 129 deals, 62 clean on every measure20211292022: 96 deals, 54 clean on every measure2022962023: 91 deals, 43 clean on every measure2023912024: 94 deals, 59 clean on every measure2024942025: 104 deals, 47 clean on every measure20251042026: 58 deals, 25 clean on every measure202658
Clean on every measure In doubt on one measure or both
Median EV / LTM EBITDA by sector
Healthcare: 13.5x median across 6 dealsHealthcare13.5xn=6Technology: 10.3x median across 9 dealsTechnology10.3xn=9Other: 5.5x median across 5 dealsOther5.5xn=5
Deals by sector
Financials: 25 dealsFinancials25Technology: 19 dealsTechnology19Healthcare: 16 dealsHealthcare16Industrials: 9 dealsIndustrials9Media & Telecom: 8 dealsMedia & Telecom8Materials: 7 dealsMaterials7Consumer & Retail: 6 dealsConsumer & Retail6Energy: 6 dealsEnergy6Other: 5 dealsOther5Real Estate: 5 dealsReal Estate5Business Services: 4 dealsBusiness Services4Utilities: 1 dealsUtilities1
Deals by buyer type
Financial sponsor: 1 dealsFinancial sponsor1Strategic: 111 dealsStrategic111Management / founder: 0 dealsManagement / founder0Controlling holder: 0 dealsControlling holder0Acquisition vehicle: 0 dealsAcquisition vehicle0Unclassified: 73 dealsUnclassified73
Deals by enterprise value
Under $250m: 52 dealsUnder $250m52$250m to $1bn: 25 deals$250m to $1bn25$1bn to $5bn: 28 deals$1bn to $5bn28$5bn to $20bn: 4 deals$5bn to $20bn4Over $20bn: 2 dealsOver $20bn2Not computed: 0 dealsNot computed0
Deals by industry code
Depository Institutions: 15 dealsDepository Institutions15Chemicals, Pharmaceuticals & Allied Products: 13 dealsChemicals, Pharmaceutic…13Business Services & Software: 13 dealsBusiness Services & Sof…13Electronics & Electrical Equipment: 9 dealsElectronics & Electrica…9Communications: 8 dealsCommunications8Oil & Gas Extraction: 5 dealsOil & Gas Extraction5Health Services: 5 dealsHealth Services5Industrial Machinery & Computers: 4 dealsIndustrial Machinery & …4Non-Depository Credit Institutions: 4 dealsNon-Depository Credit I…4Instruments, Medical Devices & Optical Goods: 3 dealsInstruments, Medical De…3
TargetAcquirerIndustryEVEV / EBITDAEV / revenuePremiumFiling
Medtox Scientific Inc
2012-06-03 · Public merger · $27.00 a share
Laboratory Corporation of America Holdings
Strategic
Healthcare$235m16.2x2.1x
37%
DEFM14A
All cash
Forestar Petroleum Corp
2012-06-03 · Public merger · $14.50 a share
Longhorn Acquisition, Inc.
Strategic
Energy$143m10.5xn.a.
34%
36% to VWAP
DEFM14A
All cash
Teledyne LeCroy, Inc.
2012-05-28 · Public merger · $14.30 a share
Teledyne Technologies Incorporated
Strategic
Industrials$235mn.a.n.a.
56%
DEFM14A
All cash
Ariba Inc
2012-05-22 · Public merger · $45.00 a share
Held out of the multiples: EV / LTM EBITDA 453.8x outside 1x to 75x
SAP America, Inc.
Strategic
Technology$4.3bn453.8x8.6x
20%
DEFM14A
All cash
Bidz.com, Inc.
2012-05-17 · Take-private · $0.78 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Glendon Group, Inc.
Strategic
Business Services$14mn.a.0.2x
n.a.
SC 13E3
All cash
Bidz.com, Inc.
2012-05-17 · Public merger · $0.78 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Glendon Group, Inc.
Strategic
Business Services$14mn.a.0.2x
n.a.
DEFM14A
All cash
Pansoft CO LTD
2012-05-16 · Take-private · $4.15 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Timesway Group Limited
Strategic
Technology$23mn.a.n.a.
106%
SC 13E3
All cash
Hilltop Holdings Inc.
2012-05-08 · Public merger · $9.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
PlainsCapital Corporation
Strategic
Financials-$72mn.a.-0.5x
n.a.
DEFM14A
Includes stock
Plainscapital Corp
2012-05-08 · Public merger · $9.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Hilltop Holdings Inc.
Strategic
Financials$854mn.a.n.a.
n.a.
DEFM14A
Includes stock
Easylink Services International Corp
2012-05-01 · Public merger · $7.25 a share
Open Text Corporation
Strategic
Technology$289mn.a.n.a.
14%
DEFM14A
All cash
Standard Microsystems Corp
2012-05-01 · Public merger · $37.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Microchip Technology Incorporated
Strategic
Technology$682m11.7x1.7x
n.a.
DEFM14A
Includes stock
Sunoco Inc
2012-04-29 · Public merger · $25.00 a share
Energy Transfer Partners, L.P.
Strategic
Energy$3.5bnn.a.0.1x
25%
DEFM14A
All cash
Gen Probe Inc
2012-04-29 · Public merger · $82.75 a share
Hologic, Inc.
Strategic
Healthcare$3.7bn21.7x6.3x
20%
DEFM14A
All cash
Georesources Inc
2012-04-24 · Public merger · $20.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Halcón Resources Corporation
Strategic
Energy$573mn.a.3.7x
23%
DEFM14A
Includes stock
Ardea Biosciences, Inc./DE
2012-04-21 · Public merger · $32.00 a share
Held out of the multiples: EV / LTM revenue 155.3x above 60x
Zeneca Inc.
Strategic
Healthcare$1.1bnn.a.155.3x
n.a.
DEFM14A
All cash
Knology Inc
2012-04-18 · Public merger · $19.75 a share
WideOpenWest Finance, LLC
Strategic
Media & Telecom$1.4bn8.0x2.7x
9%
DEFM14A
All cash
Srs Labs Inc
2012-04-16 · Public merger · $9.50 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price; EV / LTM EBITDA 101.2x outside 1x to 75x
Dts LLC
Strategic
Financials$101m101.2xn.a.
38%
DEFM14A
Includes stock
Pinnacle Summer Investments, Inc.
2012-04-16 · Take-private · $8.85 a share
The Edelman Financial Group Inc.
Strategic
Financials$239mn.a.1.4x
43%
SC 13E3
All cash
Dreams Inc
2012-04-13 · Public merger · $3.45 a share
Fanatics, Inc.
Strategic
Consumer & Retail$155m23.1x1.1x
32%
DEFM14A
All cash
Eresearchtechnology Inc /de/
2012-04-09 · Public merger · $8.00 a share
Inc.
Strategic
Business Services$348m7.5x1.8x
n.a.
DEFM14A
All cash
Ddi Corp
2012-04-03 · Public merger · $13.00 a share
Viasystems Group, Inc.
Strategic
Technology$252m7.3x0.9x
6%
DEFM14A
All cash
Ista Pharmaceuticals Inc
2012-03-26 · Public merger · $9.10 a share
Held out of the multiples: EV / LTM EBITDA 134.1x outside 1x to 75x
Bausch & Lomb Incorporated
Strategic
Healthcare$309m134.1x1.9x
10%
DEFM14A
All cash
Southern Community Financial Corp
2012-03-26 · Public merger · $3.11 a share
Capital Bank Financial Corp
Strategic
Financials$240mn.a.n.a.
59%
DEFM14A
All cash
Fortune Industries, Inc.
2012-03-26 · Take-private · $0.61 a share
Held out of the multiples: EV / LTM EBITDA 0.6x outside 1x to 75x
CEP, Inc.
Strategic
Media & Telecom$2m0.6x0.0x
n.a.
SC 13E3
All cash
Adams Golf Inc
2012-03-18 · Public merger · $10.80 a share
Taylor Made Golf Company, Inc.
Strategic
Other$68m5.5x0.7x
10%
DEFM14A
All cash

How to use a set like this

Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.

Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.

What each column means

Enterprise value.
Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
Premium.
The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
Deal type.
A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
In doubt.
A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More